Close this search box.

Akanda to contest liquidation of its Lesotho-based subsidiary

Home » Akanda to contest liquidation of its Lesotho-based subsidiary

Akanda is intending to contest the liquidation of its subsidiary, Bophelo Bio Science & Wellness, after the decision was made following an unauthorized liquidation application and request by former executive chairman of Akanda, Louisa Mojela.

Akanda has stated that Mojela was recently terminated as executive chairman of the company and the Mophuti Matsoso Development Trust (MMD Trust), which the company believes was established by Mojela.

In an action taken without the Akanda’s knowledge, the Lesotho Court has ordered an insolvent liquidation of Bophelo. It has appointed Chavonnes Cooper of Cape Town, South Africa, as liquidator of Bophelo for purposes of maintaining the value of the assets owned or managed by Bophelo. The order was signed by the Honorable Justice Mokhesi on July 15, 2022.

Read more: Akanda to supply cannabis for FDA trials of potential multi-million dollar medicine

CEO, Tej Virk, has stated that Mojela’s actions were prompted by her termination from the company, but that if the decision to reverse the liquidation is not taken, Akanda could see savings and profitability as a result of reduced expenditures and the elimination of losses associated with Bophelo.

Bophelo’s operations consist primarily of a Good Agricultural and Collection Practices (GACP) qualified hoop house and shade cloth outdoor grow site, which completed its first harvest in May 2022. 

It is generating attributed run-rate operating losses of approximately $2m (~£1.66m) annually and was previously budgeted to receive nearly $2.5m of capital investment in 2022 to construct a 2.5-acre Cravo greenhouse for the 2023 growing season.

Read more: Akanda launches new digital dispensing solution in the UK

Akanda CEO, Tej Virk, stated: “The application that was filed by Ms Mojela to place Bophelo, our wholly-owned subsidiary, in liquidation was taken without Akanda’s prior authorization, knowledge or consent. 

“We therefore have reason to believe that Ms Mojela’s actions reflect her efforts to retaliate against the company in response to her dismissal and removal from the board of directors of Akanda on 23 June, 2022, on the basis of a lack of focus on profitability under her leadership. 

“It is appalling that Ms Mojela would take the extraordinary and significant action of seeking to cause Bophelo to be declared insolvent without consulting with, or obtaining the consent of, the board of directors or the senior management team of Akanda, which is the beneficial owner of 100 per cent of Bophelo’s equity interests, or even of the full board of directors of Bophelo itself.”

Located near T’sakholo in the Mafeteng District of the Kingdom of Lesotho, Bophelo is one of the largest licensed landholders engaging in cannabis cultivation in the country. It leases the premises on which it operates from the MMD Trust, pursuant to a long-term agreement.

Akanda has stated that it intends to convene a special committee to investigate Mojela’s actions and conduct, including actions and conduct taken by her prior to her filing of the liquidation application, and will pursue all of its available legal rights and remedies against Mojela and the MMD Trust for taking this unauthorized action. 

The company also intends to contest and seek to reverse the determination by the Lesotho Court to place Bophelo in liquidation, and will seek to recover significant loans that it has made to Bophelo to fund the execution of Bophelo’s business plan, including payment of rents and staffing costs, in the event that the Lesotho Court does not reverse its determination to place Bophelo in liquidation. 

Mojela has been terminated as chairman of Bophelo for Cause, as a “bad leaver”, as a result of her improper and unauthorized action to seek to place Bophelo in liquidation.

Virk added: “Akanda believes that in this situation, Ms Mojela, our former executive chairman, failed to consider or act in the best interests of either Akanda or our shareholders. 

“We intend to reclaim what rightfully belongs to Akanda shareholders, which includes the Akanda Bokamoso Empowerment Trust, which was established to support our hard working and loyal staff at the Bophelo campus in Lesotho. While doing so, we remain committed to our mission of helping people lead better lives through improved access to high quality medical cannabis products.

“Having a presence in Africa was always about building for the long-term and making a social impact on our communities. In May 2022, Akanda acquired Portugal-based Holigen, an EU GMP-certified medical cannabis producer, which has the means to potentially contribute profits to Akanda over the next six to nine months. 

“With Holigen, Akanda believes it has more than sufficient capacity to produce premium quality indoor, outdoor and greenhouse medical cannabis within the European Union as the market matures. Additionally, with shifting market dynamics, we have found higher demand from German and UK customers for product produced in Portugal than Lesotho due to evolving EU regulations. 

“In the event, we are unable to reverse the determination of the Lesotho Court, Akanda may actually experience considerable savings and greater profitability as a result of reduced expenditures and the elimination of losses associated with Bophelo’s operations.

“Financially, the reality is that, an Akanda, without Bophelo, is on an accelerated path to profitability and positive free cash flow. As a team, we are focused on our core markets in the UK and Europe, and are already executing on a number of commercial sales agreements, all of which will leverage our Portuguese operations. 

“Despite these realities, Akanda remains committed to Bophelo, its employees and the longer-term ramp-up of cannabis markets in Africa.”

[activecampaign form=31]

Related Posts

Related Posts


Related Posts

Related Posts

Recent Posts

Related Posts

Subscribe to our mailing list to receives daily updates!

We won’t spam you


Browse by Tags




© 2023 Prohibition Holdings Ltd. All Rights Reserved.


Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?